GIRGENTI STEVEN 4

4 · bioAffinity Technologies, Inc. · Filed Feb 2, 2024

Insider Transaction Report

Form 4
Period: 2024-01-31
GIRGENTI STEVEN
DirectorExecutive Chairman
Transactions
  • Award

    Common Stock

    2024-01-31+11,943952,284 total
Holdings
  • Common Stock

    (indirect: By Trust)
    8,955
Footnotes (2)
  • [F1]Grant of restricted shares, which shares will vest pro rata on a monthly basis for 12 months commencing on February 29, 2024.
  • [F2]These shares owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"). The reporting person is a co-trustee of the Trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    ownership.xmlPrimary